Canaccord Still Buyers Of Itron Shares Despite Stock's Recent Rise
Shares of Itron, Inc. (NASDAQ: ITRI) hit a new 52-week high of $52.78 on Friday and are now higher by nearly 45 percent since the start of 2016 and more than 75 percent over the past year.
Despite the strong out-performance in Itron's stock, the risk reward profile is "favorable," at least according to John Quealy of Canaccord Genuity.
In a research report on Thursday, Quealy suggested that investors continue "building on existing positions" as his bullish stance continues to play out. Specifically, the analyst highlighted a cyclical upswing in utility metering spending and the company's cost-optimization efforts which will drive "significant earnings power enhancements."
Commenting on Itron's "very strong" second-quarter results, the analyst noted that a top- and bottom-line beat came at a time when the company faced increased costs related to an audit re-exam process.
Quealy added that revenue was also very strong for the second straight quarter, led by electric and gas gains. Meanwhile, growth in "smart" volumes rose 25 percent year-over-year and was driven by AMI contract deliveries.
In addition, the company boosted its full-year fiscal 2016 revenue/EPS outlook to $1.95 billion to $2.0 billion/$2.20–$2.245 from a prior $1.85 billion to $1.95 billion/$1.95 to $2.25.
Quealy also stated that the next catalyst for Itron's stock will be its filing of the regulatory 10-Q, followed by a meeting with the company's management.
Shares remain Buy rated with a price target boosted to $57 from a previous $50.
At time of writing, Itron shares were up 2.93 percent on Friday, trading at $52.44.
Full ratings data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!
Latest Ratings for ITRI
Date | Firm | Action | From | To |
---|---|---|---|---|
Mar 2022 | Stephens & Co. | Maintains | Overweight | |
Mar 2022 | EF Hutton | Maintains | Buy | |
Mar 2022 | Morgan Stanley | Maintains | Equal-Weight |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Analyst Color Earnings Long Ideas News Guidance Commodities Reiteration Markets Best of Benzinga